Previous close | 4.4000 |
Open | 4.4000 |
Bid | 3.4000 |
Ask | 6.3000 |
Strike | 80.00 |
Expiry date | 2025-01-17 |
Day's range | 4.4000 - 4.4000 |
Contract range | N/A |
Volume | |
Open interest | 20 |
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CAMBRIDGE, Mass., April 18, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open.
Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.